Neonatal herpes simplex virus [HSV] infection remains a common problem worldwide, affecting up to 1 of 3000 live births in the United States. Approximately 25% of infants infected with HSV develop disseminated disease [1] . Although the exact mechanisms are unclear, disseminated HSV infection has been reported as a trigger of neonatal hemophagocytic lymphohistiocytosis (HLH) [2] . A hallmark feature of this complex syndrome is a highly elevated ferritin level, with 1 recent report suggesting that a ferritin level of more than 10 000 μg/L was 96% specific for HLH [3] . We report 3 recent cases at our institution in which ferritin levels were very elevated in the setting of disseminated neonatal HSV disease. Although the diagnosis of HLH was considered, these cases call into question the specificity of ferritin >10 000 μg/L as a diagnostic marker for HLH and raise the possibility that this degree of hyperferritinemia may be related to the inflammatory effects of disseminated HSV infection alone. This conclusion, if sustained by further research, carries significant therapeutic implications given the risks of immunosuppressive therapy in the setting of concomitant disseminated infection.
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CASE 1
A 6-day-old female infant presented to the emergency department with poor feeding, respiratory distress, and lethargy. On examination, she was afebrile but cyanotic and lethargic, and she was intubated for respiratory failure. She was born at term via spontaneous vaginal delivery, weighing 3.03 kg. The postnatal course was complicated by maternal and neonatal fever, with a negative 48-hour sepsis evaluation. The patient's mother had no history of herpetic genital lesions, and the parents were previously healthy. Initial laboratory values are documented in Table 1 . Chest radiograph revealed diffuse bilateral interstitial opacities.
The infant was started on ampicillin, gentamicin, and acyclovir and admitted to the neonatal intensive care (NICU) unit for suspected sepsis with disseminated intravascular coagulation, requiring mechanical ventilation and vasopressor support. An echocardiogram showed pulmonary hypertension; therefore, she was started on inhaled nitric oxide and ultimately transitioned to venoarterial extracorporeal membrane oxidation on day of life (DOL) 7. Liver dysfunction and coagulopathy progressed, requiring aggressive transfusion support. Liver ultrasound revealed ascites and normal Doppler flow. A ferritin level obtained on DOL 7 was elevated at 68 090 μg/L. On DOL 8, HSV-2 polymerase chain reaction (PCR) returned positive in the blood and cerebrospinal fluid (CSF), and she was continued on acyclovir monotherapy. Although only meeting 4 of 8 criteria, secondary HLH was suspected on the basis of significant hyperferritinemia and cytopenias, and the hematology service was consulted.
Given her fulminant course on appropriate antiviral therapy, she was treated empirically for HLH with intravenous immunoglobulin and a dexamethasone pulse of 10 mg/m 2 daily, but she was deemed too ill for chemotherapy. Soluble interleukin 2 (SIL-2) receptor and natural killer (NK) cell activity assays were performed.
She briefly stabilized, but on DOL 12 she developed hemodynamic instability with worsening hypoxemia. Vasopressors were escalated and empiric vancomycin and cefotaxime were added. Despite maximal support, coagulopathy, oxygen extraction, and lactic acidosis progressed, and she died on DOL 14. Blood cultures grew methicillin-resistant Staphylococcus aureus from multiple cultures, with cause of death attributed to overwhelming bacterial sepsis. Natural killer cell function testing returned severely decreased, and SIL-2 receptor function was normal for age. The family declined autopsy at the time of death.
CASE 2
A 10-day-old infant presented to her pediatrician's office for fever, irritability, and poor feeding. On examination, she was noted to have a scalp vesicle and was referred to a local hospital for further evaluation. The 2.58 kg female infant was born at 39 weeks gestation via induced vaginal delivery for maternal hypertension. There was no prior history of herpetic genital lesions, although the mother developed oral lesions soon after delivery. The initial investigation revealed an irritable infant with a 2-millimeter vesicle on her left parietal scalp, and chest radiograph was normal. She was diagnosed with neonatal sepsis from suspected HSV; started on empiric ampicillin, gentamicin, and acyclovir; and transferred to our hospital for further management.
Upon arrival to our institution, the infant was vigorous but febrile to 38.7°C. Examination was notable for hepatosplenomegaly. Initial investigation revealed markedly abnormal liver studies and laboratory values as outlined in Table 1 . Ferritin level was >40 000 μg/L. On DOL 11, she was transferred to the Pediatric Intensive Care Unit for hypothermia and respiratory distress requiring brief intubation. On DOL 12, she developed seizure-like activity, and brain magnetic resonance imaging (MRI) revealed a punctate subependymal hemorrhage. Herpes simplex virus PCR from the CSF and blood returned positive for HSV-1 shortly thereafter. Hepatic dysfunction and coagulopathy progressed, with the international normalized ratio reaching 2.6. Due to concern for secondary HLH, SIL-2 receptor and NK cell activity were sent ( Table 2) . Given the patient's improvement on acyclovir, anticytokine therapy was not initiated. Despite meeting 6 of 8 criteria for HLH, her liver abnormalities and coagulopathy improved. She completed 21 days of acyclovir monotherapy, was discharged home on DOL 30, and is doing well at 6 months of life at the time of this report.
CASE 3
A male infant was evaluated by his pediatrician at DOL 9 and found to be lethargic, jaundiced, and hypothermic to 35.8°C. This infant was born at term via caesarian section for maternal pre-eclampsia, weighing 3.1 kg. Prenatal course was complicated by maternal fever and headache; the infant was discharged home on DOL 3. After his evaluation at the pediatrician's office, he was transferred to a local hospital where initial investigation yielded laboratory results outlined in Table 1 . He was started on ampicillin, gentamicin, and acyclovir for suspected neonatal sepsis and transferred to our facility. On arrival, the infant's temperature was 35.1°C and he was lethargic with poor respirations. He required continuous positive airway pressure for hypopnea. International normalized ratio was 4.7, and partial thromboplastin time was 120 seconds. Lumbar puncture was performed, and CSF was sent for culture and viral studies, but cell counts were unavailable due to a laboratory processing error. Antimicrobials were continued, and the infant was admitted to the NICU. He developed abdominal distension, and abdominal ultrasound revealed normal Doppler flow. Herpes simplex virus-1 was detected in the blood and CSF was detected by PCR on DOL 12. He subsequently developed seizures, and brain MRI showed intraventricular hemorrhage. The diagnosis of HLH was considered based on the elevated ferritin and other HLH-specific laboratory test abnormalities (Table 2) ; thus, SIL-2 receptor activity and NK cell activity assays were sent. He was not started on anticytokine therapy because he only met 3 of 8 HLH criteria. Respiratory failure developed on DOL 13 prompting intubation. Chest x-ray showed progressive opacification of bilateral lung fields. Intravenous immunoglobulin was initiated on DOL 14 given severity of illness, but his condition deteriorated and his family requested no further escalation of care. Hypoxemia progressed despite maximal ventilator settings, and care was withdrawn on DOL 16. Soluble interleukin-2 receptor and NK cell activity were within normal limits, and soluble CD163 was 9809 ng/mL (range, 399-1988). The patient's family declined an autopsy.
DISCUSSION
In this case series, 3 infants are described with massive hyperferritinemia associated with disseminated HSV infection. Given the lack of previous reports of ferritin elevation to this degree associated with neonatal HSV infection alone, a diagnosis of HLH was considered in each case. Hemophagocytic lymphohistiocytosis is a rare and frequently fatal disease with a variety of possible presentations, including acute liver failure. Treatment is aimed at decreasing cytokine activity and modulating the immune response. Diagnostic criteria exist; however, many are nonspecific and overlap with other conditions, adding to the difficulty in confirming this diagnosis. A diagnosis requires fulfillment of 5 of 8 criteria (outlined in Table 2 ) [4] .
Although uncommon in the neonatal period, several studies have associated nonfamilial HLH in the first 2 weeks of life with disseminated HSV infection [2] . A study of neonatal HLH further found that fever, hypertriglyceridemia, and neutropenia were unreliable markers in newborns, thus making HLH diagnosis in this population even more challenging [5] . Another study in children reported that ferritin over 10 000 μg/L is 90% sensitive and 96% specific for HLH, thereby making it a useful indicator for this condition [2] . All 3 patients reported had ferritin levels above this value and similar degrees of hepatic failure, but Patient 2 survived with early antiviral therapy alone. This suggests her hyperferritinemia may have been due to hepatocyte destruction from disseminated HSV disease rather than inflammation from concomitant HLH, and ferritin levels correlated closely with transaminase values for all 3 patients ( Figure 1 ). (For Patients 2 and 3, the laboratory did not dilute the sample beyond a detection level of 40 000 μg/L for ferritin.)
Overall, it remains unclear whether these cases represent (1) secondary HLH after HSV infection or (2) HSV infection alone for which supportive care and treatment with antiviral therapy may be sufficient. Notably, 2 of 3 patients in this series had HSV-1 infection. The changing epidemiology of neonatal HSV has been reported [6] with rising proportional rates of HSV-1 disease. Whether HSV-1 and HSV-2 have different predilections for hyperferritinemia and/or severe liver disease remains unclear, and the correlation of ferritin elevation with hepatic dysfunction in both disseminated HSV-1 and HSV-2 disease warrants further investigation.
The decision to treat 2 of these neonates for presumed HLH was based in part on the degree of illness as well as the known association of extreme ferritin elevations with HLH. However, these cases strongly suggest that highly elevated ferritin may not be as specific for neonatal HLH as previously suggested, and it may also be related to hepatic dysfunction and systemic inflammation from HSV or other disseminated infections. If HLH is suspected, early molecular or histologic diagnosis may be beneficial given the risks of immunosuppressive therapy, especially in the setting of systemic infection. Moreover, this series underscores the importance of treating the patient rather than the laboratory values; the only patient to fulfill diagnostic criteria for HLH (Patient 2) was also the lone survivor and improved with supportive care and acyclovir alone, without initiation of HLH-specific therapies. Conversely, the first patient in the series died of bacterial sepsis, a complication arguably related to her immunosuppression. Ultimately, both HLH and disseminated HSV portend high risk of mortality, but this risk may be further compounded by unnecessary therapies. Recognizing that massively elevated ferritin levels may be due to disseminated HSV disease could prevent potential complications of anticytokine therapy in cases where molecular evidence for HLH is lacking.
